These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21956813)

  • 21. A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery.
    Aliagas I; Gobbi A; Heffron T; Lee ML; Ortwine DF; Zak M; Khojasteh SC
    J Comput Aided Mol Des; 2015 Apr; 29(4):327-38. PubMed ID: 25708388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chelating agents and hepatic drug metabolism in the rat.
    Törrönen R; Alakuijala P; Marselos M
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):11-20. PubMed ID: 405937
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: The effect of cysteamine on the microsomal drug metabolism system.
    Mull RH; Gertz J; Flemming K
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R69. PubMed ID: 4276621
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolism of formaldehyde during in vitro drug demethylation.
    Savenije-Chapel EM; Noordhoek J
    Biochem Pharmacol; 1980 Jul; 29(14):2023-9. PubMed ID: 7406915
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro metabolic studies using homogenized horse liver in place of horse liver microsomes.
    Wong JK; Tang FP; Wan TS
    Drug Test Anal; 2011 Jun; 3(6):393-9. PubMed ID: 21381223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates.
    Fernández-Metzler CL; Owens KG; Baillie TA; King RC
    Drug Metab Dispos; 1999 Jan; 27(1):32-40. PubMed ID: 10068285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nutrition on drug metabolism and distribution.
    Woods HF
    Compr Ther; 1978 Oct; 4(10):49-53. PubMed ID: 359231
    [No Abstract]   [Full Text] [Related]  

  • 28. Microsomal and parenchymal cell models in multiple drug metabolism.
    Lowery GL; Bidlack WR
    Proc West Pharmacol Soc; 1981; 24():141-5. PubMed ID: 7255437
    [No Abstract]   [Full Text] [Related]  

  • 29. An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion.
    McNaney CA; Drexler DM; Hnatyshyn SY; Zvyaga TA; Knipe JO; Belcastro JV; Sanders M
    Assay Drug Dev Technol; 2008 Feb; 6(1):121-9. PubMed ID: 18336089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro ADME profiling using high-throughput rapidfire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays.
    Wu X; Wang J; Tan L; Bui J; Gjerstad E; McMillan K; Zhang W
    J Biomol Screen; 2012 Jul; 17(6):761-72. PubMed ID: 22460176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Symbolic Regression Model for the Prediction of Drug Binding to Human Liver Microsomes.
    Van Rompaey D; Morrison D; Van Den Bergh A; Wegner JK
    Mol Pharm; 2023 May; 20(5):2436-2442. PubMed ID: 37000176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of in silico models for fraction of unbound drug in human liver microsomes.
    Gao H; Steyn SJ; Chang G; Lin J
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):533-42. PubMed ID: 20233033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of a choline-deficient diet on drug metabolism in the rat in vivo and in vitro].
    Gallenkamp H; Sundermann D; Brachtel D; Grün M; Rasenack U; Rietbrock I; Liehr H; Richter E
    Verh Dtsch Ges Inn Med; 1974; 80():1558-61. PubMed ID: 4454484
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
    Masubuchi N; Makino C; Murayama N
    Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of age-related changes in hepatic drug metabolism in miniature swine.
    Peggins JO; Shipley LA; Weiner M
    Drug Metab Dispos; 1984; 12(3):379-81. PubMed ID: 6145568
    [No Abstract]   [Full Text] [Related]  

  • 36. 2'-Deoxyguanosine as a surrogate trapping agent for DNA reactive drug metabolites.
    Häkkinen MR; Laine JE; Juvonen RO; Auriola S; Häyrinen J; Pasanen M
    Toxicol Lett; 2011 Nov; 207(1):34-41. PubMed ID: 21907773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of drug metabolism. VII. Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats.
    Shoeman DW; Vane FM; Mannering GJ
    Mol Pharmacol; 1973 May; 9(3):373-82. PubMed ID: 4710137
    [No Abstract]   [Full Text] [Related]  

  • 38. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.
    Houston JB
    Biochem Pharmacol; 1994 Apr; 47(9):1469-79. PubMed ID: 8185657
    [No Abstract]   [Full Text] [Related]  

  • 39. Moderate correlations of in vitro versus in vivo pharmacokinetics questioning the need of early microsomal stability testing.
    Schrezenmeier E; Zollmann FS; Seidel K; Böhm C; Schmerbach K; Kroh M; Kirsch S; Klare S; Bernhard S; Kappert K; Goldin-Lang P; Skuballa W; Unger T; Funke-Kaiser H
    Pharmacology; 2012; 90(5-6):307-15. PubMed ID: 23037500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug metabolism and toxicity].
    Kitagawa H
    Rinsho Byori; 1973 May; 21(5):413-21. PubMed ID: 4738038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.